Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03193801 · ClinicalTrials.gov registry record · NA
PARTNER 3 Trial - Mitral Valve in Valve
A NA study of Heart Failure and Mitral Valve Insufficiency, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 12
- Study locations
NCT03193801 is a NA study of Heart Failure and Mitral Valve Insufficiency that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 53 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 12 study locations across 10 states.
The verdict
NCT03193801, a NA study of Heart Failure and Mitral Valve Insufficiency, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 12
- Study locations
Study Summary
To assess the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with a failing mitral bioprosthetic valve.
Conditions Studied
Interventions
- DEVICE Edwards SAPIEN 3 transcatheter valve, Model 9600TFX
Study Locations (12)
Illinois
- Northwestern University - Chicago
- Northshore University Health System Research Institution - Evanston
São Paulo
- Instituto do Coração da Universidade de São Paulo - Cerqueira César
- Instituto Dante Pazzanese de Cardiologia - Vila Mariana
Georgia
- Emory University - Atlanta
Massachusetts
- Brigham and Women's Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
Missouri
- Barnes-Jewish Hospital/ Washington University - St Louis
New York
- NYU Lagone Medical Center - New York
Oregon
- Providence Heart & Vascular Institution - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2031-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03193801
The ClinicalTrials.gov registry entry for NCT03193801 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Edwards SAPIEN 3 transcatheter valve, Model 9600TFX is the first listed.
NCT03193801 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Illinois, São Paulo, Georgia.
Frequently Asked Questions
What is clinical trial NCT03193801 about?
NCT03193801 is a clinical study titled "PARTNER 3 Trial - Mitral Valve in Valve". To assess the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with a failing mitral bioprosthetic valve.
What is the current status of trial NCT03193801?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 53 participants. The study started on 2018-02-01. Estimated completion is 2031-08.
What conditions does trial NCT03193801 study?
This clinical trial studies the following conditions: Heart Failure, Mitral Valve Insufficiency, Mitral Valve Regurgitation, Mitral Valve Disease.
What interventions are being tested in trial NCT03193801?
The interventions under investigation include: Edwards SAPIEN 3 transcatheter valve, Model 9600TFX (DEVICE).
Who is sponsoring clinical trial NCT03193801?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03193801 being conducted?
This trial has 12 study locations across Georgia, Illinois, Massachusetts, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.